Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
COLLEGEVILLE, Pennsylvania, October 15 /PRNewswire/ --
- Company Underscores Commitment to Availability in Worldwide Markets
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today provided an…